Image default
Business Partnerships

Deinove teams up with Dow to develop bacteria-based cosmetic ingredient.

“This first collaboration with Deinove is perfectly aligned with our strategy of expanding and transforming our portfolio dedicated to skin care.”

French biotech company Deinove has announced a collaboration with US chemicals giant Dow (@DowNewsroom)for the joint development of a cosmetic ingredient derived from its collection of bacterial extracts.

In a statement, Deinove (@Deinove) said it owned a large bacterial collection that today includes more than 6,000 rare strains, collected in many different biotopes (hot springs, volcanos, lagoons, beaches, caves…) and on various substrates (nearly 600 samples of wood, water, plant, sand, etc.).

The company has developed original and patented methods for the selection and culture of these rare bacteria. Several of these strains have been qualified via Deinove ‘s cell biology lab according to their properties on different cosmetic activities (anti-oxidant, anti-inflammatory, cell regeneration…).

Under the new partnership, Dow has selected one extract from Deinove’s bacterial bank. Deinove will now develop and optimise a dedicated production process and will ensure the industrial transposition and production of the developed cosmetic active.

Dow said it will leverage its expertise and cell biology laboratory in Belgium to qualify the cosmetic active and integrate it into its product portfolio. It is hoped that this will lead to commercial exclusivity worldwide.

Fabienne Bizeray, Dow’s Global Strategic Marketing Leader Skin & Sun Care, said: “We have chosen Deinove for its widely recognised expertise in biotechnology and valuation of rare microorganisms. After the launch of AgeCap Smooth in April 2018, this agreement will allow Dow to quickly develop a new natural cosmetic ingredient for our customers.

“This first collaboration with Deinove is perfectly aligned with our strategy of expanding and transforming our portfolio dedicated to skin care.”

“We are proud that a big industrial leader such as Dow has been convinced by our expertise and attracted by the richness of our bacterial collection. This agreement values the quality of our R&D approach and our portfolio of cosmetic actives.” added Emmanuel Petiot, CEO of Deinove.

If you were interested in this cosmetic-based story, you may also be interested in these ones below.

Read: Shiseido teams up with Kaneka to develop biodegradable cosmetic packaging.

Read: Unilever and Bio-on officially unveil new sunscreens made from biodegradable bioplastics.

Read: UK researchers use synthetic biology to make drug-producing bacteria.

Take part:  Bio Market Insights reader survey 2019.

Related posts

After a decade of R&D, ground is broken on Clariant’s cellulosic ethanol plant in Romania.

Luke Upton

5 Minutes With…Rick Passenier from the Global Organization for PHA – GO!PHA

Liz Gyekye

5 Minutes With… Irina Price, Director & Co-Founder, EcoOutfitters

Emily Odowd

Leave a Comment

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More